Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Globalisation of cancer clinical trials linked to lower enrolment of Black patients
For the drug approval process in the United States, investigators have been expanding clinical trials…
Unburdening China of cancer: trend analysis to assist prevention measures
The past century or so has seen unprecedented technological, scientific, and sociological evolution worldwide. These…
Brain cancer: may be linked to mind-altering cat parasite
A new study suggests a link between toxoplasma gondii (T. gondii) infection and the risk of glioma,…
Recycling approved drugs for cancer treatment
- ASTRO 2016: Radiation therapy and radical prostatectomy explored further for initial diagnosis of advanced prostate cancer
- ASTRO 2016: Intermediate risk prostate cancer may be well controlled with brachytherapy alone
- Active monitoring as effective for prostate cancer as surgery and radiotherapy, in terms of survival at 10 years
A better way to estimate Australia’s future lifestyle-related cancers
By Gabrielle Dunlevy. UNSW’s Centre for Big Data Research in Health has a new and improved way to estimate the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.